Start-Up Spotlight: Aria CV Addresses Right-Heart Failure With Purely Mechanical Solution

St. Paul-based Aria CV is developing a "passive" pulmonary artery balloon system to treat pulmonary hypertension and impede the development of heart failure. Following a successful first-in-human study, the company is currently developing a feasibility study it expects will lead to a US pivotal trial in several years.

Start-up Spotlight

Aria CV hopes to address pulmonary hypertension, a potentially devastating condition that currently has few treatments, with a unique balloon device that requires no power supply, battery, pump, or synchronization.

Pulmonary hypertension increases "afterload" on the right ventricle, which contributes to right-heart failure, but there are not many options to treat it, Aria CV CEO and co-founder John Scandurra told...

Aria CV
  • Mailing Address: 2300 Myrtle Avenue, Suite 250, St. Paul, MN 55114

  • Website:

More from Business

More from Medtech Insight